[ FDA ENFORCEMENT INTELLIGENCE ]

Learn from the record. Every FDA recall is a quality signal.

Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.

1,000
Total recalls
217
Class I (most serious)
167
Drug
515
Device
318
Food / supplement / cosmetic
Last 12 months · latest report 2026-07-22 · source: openFDA enforcement
RECALLS BY CLASSIFICATION · MONTHLY
RECALL REASONS BY QUALITY DOMAIN

Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.

Reset
1,158 matching recalls
DateClassFirmReasonQuality domain
2026-05-27Class IIMedtronic Perfusion SystemsZ-2214-2026Certain lots of product have the potential for a sterile barrier breach.Environmental Monitoring
2026-05-27Class IIPHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Z-2225-2026Potential safety issue with Philips Azurion systems, where longitudinal and transverse table movements may be impacted due to mechanical wear of the Float Tabletop control on the control module.
2026-05-27Class IIMedtronic Perfusion SystemsZ-2219-2026Certain lots of product have the potential for a sterile barrier breach.Environmental Monitoring
2026-05-27Class IIBecton, Dickinson and CompanyZ-2204-2026Catheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss.Risk Management & CAPA
2026-05-27Class IIMedtronic Perfusion SystemsZ-2218-2026Certain lots of product have the potential for a sterile barrier breach.Environmental Monitoring
2026-05-27Class IIMedtronic Perfusion SystemsZ-2217-2026Certain lots of product have the potential for a sterile barrier breach.Environmental Monitoring
2026-05-27Class IIMedtronic Perfusion SystemsZ-2222-2026Certain lots of product have the potential for a sterile barrier breach.Environmental Monitoring
2026-05-27Class IIBecton, Dickinson and CompanyZ-2202-2026Catheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss.Risk Management & CAPA
2026-05-27Class IIPHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Z-2227-2026The deaeration hose in X-ray tube cooling units type CU3101, manufactured between February 2016 and May 2020, may degrade over time, potentially resulting in oil leakage. Oil leakage may affect the cooling performance of the X-ray tube. When the oil flow drops below a certain threshold, the system automatically switches to low-dose fluoroscopy and displays the message Low load fluoroscopy flavor selected: Tube cooler problem . This condition cannot be resolved by restarting the system.Validation & Qualification
2026-05-27Class IIMedtronic Perfusion SystemsZ-2220-2026Certain lots of product have the potential for a sterile barrier breach.Environmental Monitoring
2026-05-20Class IIStryker Sustainability SolutionsZ-2177-2026Incomplete seals on sterile productEnvironmental Monitoring
2026-05-20Class IIStryker Sustainability SolutionsZ-2176-2026Incomplete seals on sterile productEnvironmental Monitoring
2026-05-20Class IIGE Medical Systems, LLCZ-2149-2026GE HealthCare has become aware of a potential security vulnerability impacting AW Server deployed via Edison Health Link (EHL) based CT Smart Subscription used in conjunction with certain Revolution Apex, Revolution Ascend, and Revolution CT systems.Data Integrity
2026-05-20Class IIPHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Z-2170-2026Potential for the bolts and plastic parts of the Cable Hose Carriers that hold the cable hose to the monitor ceiling suspension may loosen and/or break over time due to the forces applied when the monitor is moved or rotated.
2026-05-20Class IWindstone Medical Packaging, Inc.Z-2066-2026Affected kits contain Medline Namic RA Syringes, which are recalled by their manufacturer due to risk of syringe rotating adapter unwinding during use, which may result in a loose connection or full disconnection between syringe and manifold. If unwinding occurs, there is a potential for biohazard exposure, blood loss, infection. or air embolism.
2026-05-20Class IIStryker Sustainability SolutionsZ-2197-2026Incomplete seals on sterile productEnvironmental Monitoring
2026-05-20Class IOmnicell, Inc.Z-2047-2026Potential for mislabeled syringe produced by the i.v.STATION device.Documentation & Change Control
2026-05-20Class IIHologic, IncZ-2167-2026Complaints have been received of systems developing loose, missing, or broken internal bolts over time.
2026-05-20Class IIStryker Sustainability SolutionsZ-2185-2026Incomplete seals on sterile productEnvironmental Monitoring
2026-05-20Class IIStryker Sustainability SolutionsZ-2191-2026Incomplete seals on sterile productEnvironmental Monitoring
2026-05-20Class IIOn-X Life Technologies, Inc.Z-2133-2026Heart valves were released and distributed before all required testing was complete, so it cannot be confirmed that they meet all release specifications.
2026-05-20Class IMedline Industries, LPZ-2148-2026Medline has identified the presence of particulate within the fluid path of the Manifolds.Environmental Monitoring
2026-05-20Class IIStryker Sustainability SolutionsZ-2181-2026Incomplete seals on sterile productEnvironmental Monitoring
2026-05-20Class IMedline Industries, LPZ-2141-2026Medline has identified the presence of particulate within the fluid path of the Manifolds.Environmental Monitoring
2026-05-20Class IIMedtronic NeuromodulationZ-2201-2026Software issue: When programming the SynchroMed Pump with the A810 CP App in Flex Infusion Mode, the infusion steps should automatically be arranged in consecutive order, from earliest to latest. However, in rare cases, the steps may be displayed out of order. If this occurs, the programmed Flex Infusion schedule will not be delivered at the intended time, if at all.
Page 22 of 47
← PrevNext →

Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.